NCT01704053View on ClinicalTrials.gov

Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Clot Formation and Platelet Aggregation in Point of Care Testing
Trial Locations (1)

60590

University Hospital of University hospital of Frankfurt/Main, Department of Anesthesiology, Intensive-Care Medicine and Pain Therapy, Frankfurt am Main

All Listed Sponsors
lead

Johann Wolfgang Goethe University Hospital

OTHER

NCT01704053 - Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study | Biotech Hunter | Biotech Hunter